Sponsor Pipeline

St Vincent's Hospital, Sydney Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
5
Recruiting
4
Disease Areas
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-15 NCT06907641
Comparative Performance of 64Copper [64Cu]-SAR-bis-PSMA vs 68Ga PSMA-11 PET CT for the…		 Trial completed
2026-08-15 NCT06907641
Comparative Performance of 64Copper [64Cu]-SAR-bis-PSMA vs 68Ga PSMA-11 PET CT for the…		 date change Primary completion moved earlier: 2025-11 -> 2025-09-03
2026-08-15 NCT06907641
Comparative Performance of 64Copper [64Cu]-SAR-bis-PSMA vs 68Ga PSMA-11 PET CT for the…		 date change Completion moved earlier: 2025-11 -> 2025-09-03
Active Trials by Phase
Phase 2
1
Phase 1/2
2
Phase 1
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT03522064 Bipolar Androgen Therapy + Carboplatin in mCRPC Castration-resistant Prostate Cancer Recruiting
Phase 1/2
NCT04947189 Seviteronel in Combination With Chemotherapy in Androgen-receptor Positive Metastatic… Triple Negative Breast Cancer Recruiting
NCT07063875 Adding IL-2 to Tebentafusp to Eradicate Cancer Progression Uveal Melanoma Recruiting
Phase 1
NCT07203391 Tebentafusp and Roginolisib in Uveal Melanoma to Prolong T-cell Homeostasis Uveal Melanoma, Metastatic Recruiting
Not specified
NCT07552922 Determining INdividual Preferences for Gynecomastia avOidance (DINGO) - Stage 1 Prostate Cancer (Adenocarcinoma) Recruiting
Disease Areas
Prostate Cancer (2) Melanoma (2) Breast Cancer (1) Triple-Negative Breast Cancer (1)
Get alerts when St Vincent's Hospital, Sydney's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free